7120-41-4

Basic information

• Product Name: methyl 5-bromo-2-methoxybenzoate
• Synonyms: methyl 5-bromo-2-methoxybenzoate;2-Methoxy-5-broMobenzoic acid Methyl ester
• CAS NO: 7120-41-4
• Molecular Formula: C₉H₉BrO₃
• Molecular Weight: 245
• Mol File: 7120-41-4.mol
• Article Data: 24

Chemical Properties

• Boiling Point: 295.186°C at 760 mmHg
• Flash Point: 132.324°C
• Appearance: /
• Density: 1.463g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.538
• Storage Temp.: 2-8°C
• CAS DataBase Reference: methyl 5-bromo-2-methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-bromo-2-methoxybenzoate(7120-41-4)
• EPA Substance Registry System: methyl 5-bromo-2-methoxybenzoate(7120-41-4)

Safety Data

• Hazardous Substances Data: 7120-41-4(Hazardous Substances Data)

Usage

General Description

Methyl 5-bromo-2-methoxybenzoate is a chemical compound with the molecular formula C9H9BrO3. It is a white to off-white solid that is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. This chemical is also known for its use as a reagent in the preparation of various esters and ethers through esterification and Williamson ether synthesis reactions. Methyl 5-bromo-2-methoxybenzoate is a versatile compound that has a wide range of applications in the field of organic chemistry and drug discovery. Its diverse reactivity and functional groups make it a valuable building block in the synthesis of complex organic molecules.

InChI:InChI=1/C9H9BrO3/c1-12-8-4-3-6(10)5-7(8)9(11)13-2/h3-5H,1-2H3

Upstream product

• 4068-76-2 5-bromo-2-hydroxy-benzoic acid methyl ester 
• 74-88-4 methyl iodide 
• 89-55-4 5-bromosalicyclic acid 
• 67-56-1 methanol 
• 135-02-4 ortho-anisaldehyde 
• 77-78-1 dimethyl sulfate 
• 606-45-1 2-methoxybenzoic acid methyl ester 
• 2476-35-9 5-bromo-2-methoxybenzoic acid 
• 612-16-8 (2-methoxyphenyl)methanol 
• 1638291-19-6 5-bromo-2-methoxy-N-methyl-N-(4-methylbenzenesulfonyl)benzenecarboxamide 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 18107-18-1 diazomethyl-trimethyl-silane 

Downstream Products

• 26561-07-9 2',4'-Dimethoxy-diphenylaether-3,4'-dicarbonsaeure-dimethylester 
• 2476-35-9 5-bromo-2-methoxybenzoic acid 
• 148014-81-7 C₁₈H₁₈O₇ 
• 202822-79-5 5-(1H-imidazol-1-yl)-2-methoxybenzoic acid methyl ester 
• 478375-37-0 methyl 2-methoxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzoate 
• 202822-80-8 5-(1H-imidazol-1-yl)-2-methoxybenzenemethanol 
• 927811-65-2 3-[[2-methoxy-5-(1H-imidazol-1-yl)phenyl]methyl]-5-[4-(trifluoromethyl)-phenyl]-1,3,4-oxadiazol-2-(3H)-one 
• 148014-77-1 bis(3-carboxy-4-methoxyphenyl) ether 
• 148014-78-2 C₁₆H₁₂Cl₂O₅ 
• 148014-79-3 C₆₄H₅₈O₁₃ 
• 62910-63-8 5-bromo-2-methoxybenzoyl chloride 
• 54450-20-3 5-bromo-3(2H)-benzofuranone 
• 857591-20-9 2-benzhydryl-4-bromo-anisole 
• 102024-94-2 4-bromo-2-(α-chloro-benzhydryl)-anisole 

Relevant articles and documents

MODIFIED PROTEINS AND PROTEIN DEGRADERS

Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.

Cooperative Carbon Dioxide Adsorption in Alcoholamine- and Alkoxyalkylamine-Functionalized Metal–Organic Frameworks

A series of structurally diverse alcoholamine- and alkoxyalkylamine-functionalized variants of the metal–organic framework Mg2(dobpdc) are shown to adsorb CO2 selectively via cooperative chain-forming mechanisms. Solid-state NMR spec

Sulfonamide compound and medical applications thereof

The invention discloses a compound containing a sulfonamide structure, a preparation method thereof, and medical applications of the compound, and more specifically discloses the compound with a structure represented by formula I, and a pharmaceutically acceptable salt or a prodrug or a solvate thereof. The compound is used for tumor treatment through inhibiting ATP-citrate lyase.